Related Experiment Videos
Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats
A V Kulikov1, V G Kolpakov, G B Maslova
1Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk.
Abstract:
The effects of the selective 5-HT1A agonists 8-OH-DPAT and flesinoxan and the selective 5-HT2 antagonists ritanserin and ketanserin on immobility time in rats bred for predisposition to catalepsy have been studied. Treatment with 8-OH-DPAT as well as flesinoxan caused a marked dose-dependent decrease in immobility time. Ritanserin and ketanserin did not affect immobility time at any dose tested. It was suggested that 5HT1A rather than 5-HT2 serotonin receptors are involved in the catalepsy and that an hereditary predisposition to catalepsy may be the result of an inherited alteration in 5-HT1A receptors.
Insights
Selective serotonin 5-HT1A agonists, 8-OH-DPAT and flesinoxan, reduced immobility in rats. Selective serotonin 5-HT2 antagonists, ritanserin and ketanserin, had no effect, suggesting 5-HT1A receptor involvement in hereditary catalepsy.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Catalepsy is a motor disorder characterized by a lack of movement.
- Hereditary predisposition to catalepsy suggests a genetic component.
- Serotonin receptors, particularly 5-HT1A and 5-HT2 subtypes, play roles in motor control.
Purpose of the Study:
- To investigate the role of serotonin 5-HT1A and 5-HT2 receptors in an animal model of hereditary catalepsy.
- To determine the effects of selective 5-HT1A agonists and 5-HT2 antagonists on immobility time in rats predisposed to catalepsy.
Main Methods:
- Administration of selective 5-HT1A agonists (8-OH-DPAT, flesinoxan) and 5-HT2 antagonists (ritanserin, ketanserin) to rats bred for catalepsy.
- Measurement of immobility time as an indicator of catalepsy.
- Dose-response analysis of drug effects.
Main Results:
- Treatment with 8-OH-DPAT and flesinoxan resulted in a significant, dose-dependent decrease in immobility time.
- Ritanserin and ketanserin did not alter immobility time at any tested dose.
- These findings indicate a specific role for 5-HT1A receptors in modulating catalepsy.
Conclusions:
- The study suggests that 5-HT1A serotonin receptors, rather than 5-HT2 receptors, are critically involved in the manifestation of catalepsy.
- An inherited predisposition to catalepsy may stem from alterations in the function or structure of 5-HT1A receptors.
- These findings provide insights into the neurobiological underpinnings of hereditary motor disorders and potential therapeutic targets.